What is the ticker symbol for SciSparc?

SciSparc trades under the ticker SPRC on NASDAQ.

What sector does SciSparc operate in?

SciSparc is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SPRC in a portfolio?

PortView shows SPRC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

SciSparc (SPRC) Stock Analysis

NASDAQHealthcareBiotechnology

$5.75+1.41%

1-year price historyRange $3.06 – $54.81

52-week range$5.75

$2.98$80.10

What SciSparc does

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.

Key metrics

Market cap

$332,574

P/E (TTM)

-0.04

EPS (TTM)

$-161.98

Beta

2.45

Dividend yield

0.00%

Revenue / share

$21.08

50-day avg

$6.05

200-day avg

$8.20

52-week high

$80.10

52-week low

$2.98

CEO

Oz Adler

ETFs linked to SPRC

Broad-market and Healthcare sector ETFs an investor holding SciSparc is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SPRC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SPRC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for SciSparc?: SciSparc trades under the ticker SPRC on NASDAQ.
Which exchange is SPRC listed on?: SPRC is listed on NASDAQ.
What sector does SciSparc operate in?: SciSparc is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SPRC in a portfolio?: PortView shows SPRC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.